111 related articles for article (PubMed ID: 2999394)
1. Angiotensin converting enzyme inhibitors: structure-activity profile of 1-benzazepin-2-one derivatives.
Stanton JL; Watthey JW; Desai MN; Finn BM; Babiarz JE; Tomaselli HC
J Med Chem; 1985 Nov; 28(11):1603-6. PubMed ID: 2999394
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological properties of (carboxyalkyl)amino-substituted bicyclic lactam inhibitors of angiotensin converting enzyme.
Watthey JW; Stanton JL; Desai M; Babiarz JE; Finn BM
J Med Chem; 1985 Oct; 28(10):1511-6. PubMed ID: 2995669
[TBL] [Abstract][Full Text] [Related]
3. Studies on angiotensin converting enzyme inhibitors. 4. Synthesis and angiotensin converting enzyme inhibitory activities of 3-acyl-1-alkyl-2-oxoimidazolidine-4-carboxylic acid derivatives.
Hayashi K; Nunami K; Kato J; Yoneda N; Kubo M; Ochiai T; Ishida R
J Med Chem; 1989 Feb; 32(2):289-97. PubMed ID: 2913292
[TBL] [Abstract][Full Text] [Related]
4. Rapid reversal of angiotensin I-induced contractions in rat carotid arteries after acute and chronic treatment with the angiotensin-converting enzyme inhibitor, 3-[(5-amino-1-carboxy-1S-pentyl)amino]2,3,4,5-tetrahydro-2-oxo- 3S-1H-1-benzazepena-1-acetic acid (CGS 16617).
Weiss GB; Sturm B; Levens NR
J Pharmacol Exp Ther; 1993 Dec; 267(3):1407-13. PubMed ID: 8263802
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and anthelmintic activity of a series of pyrazino[2,1-a][2]benzazepine derivatives.
Brewer MD; Burgess MN; Dorgan RJ; Elliott RL; Mamalis P; Manger BR; Webster RA
J Med Chem; 1989 Sep; 32(9):2058-62. PubMed ID: 2769679
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin converting enzyme inhibitors: 1,5-benzothiazepine derivatives.
Slade J; Stanton JL; Ben-David D; Mazzenga GC
J Med Chem; 1985 Oct; 28(10):1517-21. PubMed ID: 2995670
[TBL] [Abstract][Full Text] [Related]
7. Derivatives of the potent angiotensin converting enzyme inhibitor 5(S)-benzamido-4-oxo-6-phenylhexanoyl-L-proline: effect of changes at positions 2 and 5 of the hexanoic acid portion.
Almquist RG; Crase J; Jennings-White C; Meyer RF; Hoefle ML; Smith RD; Essenburg AD; Kaplan HR
J Med Chem; 1982 Nov; 25(11):1292-9. PubMed ID: 6292422
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of 5-hydroxy-2,3,4,5-tetrahydro-[1H]-2-benzazepin-4-ones: selective antagonists of muscarinic (M3) receptors.
Bradshaw B; Evans P; Fletcher J; Lee AT; Mwashimba PG; Oehlrich D; Thomas EJ; Davies RH; Allen BC; Broadley KJ; Hamrouni A; Escargueil C
Org Biomol Chem; 2008 Jun; 6(12):2138-57. PubMed ID: 18528576
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin converting enzyme inhibitors: N-substituted D-glutamic acid gamma dipeptides.
Ksander GM; Yuan AM; Diefenbacher CG; Stanton JL
J Med Chem; 1985 Nov; 28(11):1606-11. PubMed ID: 2999395
[TBL] [Abstract][Full Text] [Related]
10. Improved glucose metabolism following blockade of angiotensin converting enzyme but not angiotensin AT1 receptors.
Chow L; De Gasparo M; Levens N
Eur J Pharmacol; 1995 Aug; 282(1-3):77-86. PubMed ID: 7498292
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-converting enzyme inhibition, anti-hypertensive activity and hemodynamic profile of trandolapril (RU 44570).
Brown NL; Badel MY; Benzoni F; Zanirato J; Vincent JC; Fichelle J; Worcel M
Eur J Pharmacol; 1988 Mar; 148(1):79-91. PubMed ID: 3383998
[TBL] [Abstract][Full Text] [Related]
12. Mercaptoacyl dipeptides as orally active dual inhibitors of angiotensin-converting enzyme and neutral endopeptidase.
Fink CA; Carlson JE; McTaggart PA; Qiao Y; Webb R; Chatelain R; Jeng AY; Trapani AJ
J Med Chem; 1996 Aug; 39(16):3158-68. PubMed ID: 8759637
[TBL] [Abstract][Full Text] [Related]
13. MDL 100240.
Drugs R D; 1999 Apr; 1(4):348-9. PubMed ID: 10566061
[No Abstract] [Full Text] [Related]
14. Synthesis and pharmacology of the potent angiotensin-converting enzyme inhibitor N-[1(S)-(ethoxycarbonyl)-3-phenylpropyl]-(S)-alanyl-(S)-pyroglutamic acid.
Johnson AL; Price WA; Wong PC; Vavala RF; Stump JM
J Med Chem; 1985 Nov; 28(11):1596-602. PubMed ID: 2999393
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin converting enzyme inhibitors: spirapril and related compounds.
Smith EM; Swiss GF; Neustadt BR; McNamara P; Gold EH; Sybertz EJ; Baum T
J Med Chem; 1989 Jul; 32(7):1600-6. PubMed ID: 2544729
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular effects of the novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme BMS-182657 in experimental hypertension and heart failure.
Trippodo NC; Robl JA; Asaad MM; Bird JE; Panchal BC; Schaeffer TR; Fox M; Giancarli MR; Cheung HS
J Pharmacol Exp Ther; 1995 Nov; 275(2):745-52. PubMed ID: 7473162
[TBL] [Abstract][Full Text] [Related]
17. Effects of benazepril, an angiotensin-converting enzyme inhibitor, combined with CGS 35066, a selective endothelin-converting enzyme inhibitor, on arterial blood pressure in normotensive and spontaneously hypertensive rats.
Battistini B; Ayach B; Molez S; Blouin A; Jeng AY
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():363S-366S. PubMed ID: 12193123
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin converting enzyme inhibitors: 1-glutarylindoline-2-carboxylic acids derivatives.
Gruenfeld N; Stanton JL; Yuan AM; Ebetino FH; Browne LJ; Gude C; Huebner CF
J Med Chem; 1983 Sep; 26(9):1277-82. PubMed ID: 6310113
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin converting enzyme inhibitors: N-substituted monocyclic and bicyclic amino acid derivatives.
Stanton JL; Gruenfeld N; Babiarz JE; Ackerman MH; Friedmann RC; Yuan AM; Macchia W
J Med Chem; 1983 Sep; 26(9):1267-77. PubMed ID: 6310112
[TBL] [Abstract][Full Text] [Related]
20. Bicyclic lactam inhibitors of angiotensin converting enzyme.
Watthey JW; Gavin T; Desai M
J Med Chem; 1984 Jun; 27(6):816-8. PubMed ID: 6330355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
